What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Surgery, Internal medicine, Cancer, Pathology and Cancer research are his primary areas of study.
Dong M. Shin regularly links together related areas like Hazard ratio in his Surgery studies.
His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His work on Cancer prevention as part of general Cancer study is frequently connected to Extramural, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research integrates issues of Carcinogenesis and Head and neck cancer in his study of Pathology.
His Cancer research research is multidisciplinary, relying on both Epidermal growth factor receptor, Oncogene, Chromatin, Growth factor receptor and In vivo.
His most cited work include:
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck (3893 citations)
- Nanoparticle therapeutics: an emerging treatment modality for cancer (3132 citations)
- Therapeutic Nanoparticles for Drug Delivery in Cancer (2025 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cancer research, Cancer, Oncology and Head and neck cancer.
His Internal medicine research integrates issues from Gastroenterology and Surgery.
His studies in Surgery integrate themes in fields like Epidermoid carcinoma and Hazard ratio.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell culture, Cell growth, Cancer cell, Head and neck squamous-cell carcinoma and Apoptosis.
His research investigates the connection between Cancer and topics such as Pathology that intersect with problems in Carcinogenesis.
The concepts of his Head and neck cancer study are interwoven with issues in Disease and Epidermal growth factor receptor.
He most often published in these fields:
- Internal medicine (39.75%)
- Cancer research (33.19%)
- Cancer (32.77%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (39.75%)
- Oncology (30.23%)
- Cancer research (33.19%)
In recent papers he was focusing on the following fields of study:
Dong M. Shin mostly deals with Internal medicine, Oncology, Cancer research, Cancer and Head and neck cancer.
Dong M. Shin has researched Internal medicine in several fields, including Gastroenterology and Head and neck.
His Oncology research also works with subjects such as
- Human papillomavirus which intersects with area such as Presentation,
- Stage that intertwine with fields like Confidence interval and Hazard ratio,
- Socioeconomic status which intersects with area such as Hpv status.
Dong M. Shin interconnects Cetuximab, Cell growth, Cancer cell, Kinase and In vivo in the investigation of issues within Cancer research.
His work deals with themes such as Lung cancer and Carcinoma, which intersect with Cancer.
His research on Head and neck cancer also deals with topics like
- Inflammation which intersects with area such as Tumor necrosis factor alpha,
- Immune system which connect with Human leukocyte antigen.
Between 2016 and 2021, his most popular works were:
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (125 citations)
- Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas (124 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Cancer research, Cancer, Internal medicine, Oncology and Cancer cell.
His Cancer research research is multidisciplinary, incorporating perspectives in Cell growth, Oncogene, Transcription factor, microRNA and Kinase.
His Cancer study incorporates themes from Neuroendocrine tumors, Lymph node, Proportional hazards model and Lung.
His Proportional hazards model course of study focuses on Esophagectomy and Surgery.
The various areas that Dong M. Shin examines in his Oncology study include Cetuximab, Head and neck squamous-cell carcinoma, Head and neck cancer, Carcinoma and Stage.
His research integrates issues of Inflammation and Incidence in his study of Head and neck cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
